Tumor Imaging Metrics
- Gordon Harris, PhD; Matthew A. Barish, MD; Annick D. Van Den Abbeele, MD, Vaibhav Sahai, MBBS, Trinity Urban, William B. Hanlon, MS, Vadim Frenkel, Deirdre Pierce. DF/HCC Tumor Imaging Metrics Core - Association of American Cancer Institutes Annual Fall Meeting 2006
- Harris G, Barish MA, Van Den Abbeele A, Hanlon W, Urban T, Sahai V, Frenkel V, Pierce D. Tumor Imaging Metrics Core. Poster at Dana Farber Brigham and Women's Cancer Center (DF/BWCC) Community Forum on June 9, 2006.
A. D. Van den Abbeele, J. T. Yap, D. S. Grayzel, J. Walker, G. D. Demetri. Inhibition and flare patterns of metabolic response to the Heat Shock Protein (Hsp90) inhibitor IPI-504 visualized by FGD-PET in patients with gastrointestinal stromal tumors (GIST) resistant to tyrosine kinase inhibitor therapy. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 3530
- Urban T, Van den Abbeele A, Barish M, Oliveira G, Zondervan R, Hanlon W, and Harris G. Benefits of Utilizing Image Analysts for Radiological Measurements in Oncology Clinical Trials. RSNA 2008 Annual Meeting.
- Urban T, Harris G, Barish M, Oliveira G, Zondervan R, Hanlon W. Benefits of Image Analysts. Applied Clinical Trials, May 2009 Supplement.
TIMC News Articles: